Alexander Egbe, MBBS, MPH
Mayo Clinic
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Alexander Egbe, MBBS, MPH as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:51 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06678256 · A Study of Pregnancy Outcomes in Congenital Heart DiseaseMayo Clinic · withdrawn · Congenital Heart Disease · principal investigator
- Ph3NCT06150560 · A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)Mayo Clinic · recruiting · Coarctation of Aorta, High Blood Pressure · principal investigator
- N/ANCT05849025 · A Study of Invasive Hemodynamic for MACHD RegistryMayo Clinic · recruiting · Healthy, Congenital Heart Disease · principal investigator
- N/ANCT05773300 · Registry for Mayo Clinic Adult Congenital Heart Disease Control PopulationMayo Clinic · active not recruiting · Healthy · principal investigator
- N/ANCT05122962 · Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart DiseasesMayo Clinic · recruiting · Tetralogy of Fallot, Congenital Heart Disease · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:51 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Mechanisms of Clinical and Hemodynamic Response to Pulmonary Vasodilator Therapy in Fontan physiologyR01HL160761 · NHLBI · MAYO CLINIC ROCHESTER · PI Alexander Egbe · fiscal years 2022 to 2026Named on NCT06678256, NCT05849025
- Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aortaR01HL162830 · NHLBI · MAYO CLINIC ROCHESTER · PI Alexander Egbe · fiscal years 2023 to 2026Named on NCT06150560
- Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of FallotR01HL158517 · NHLBI · MAYO CLINIC ROCHESTER · PI Alexander Egbe · fiscal years 2021 to 2025Named on NCT05773300, NCT05122962
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.